Structural Insights into the Evolution of a Non-Biological Protein: Importance of Surface Residues in Protein Fold Optimization by Smith, Matthew D. et al.
Structural Insights into the Evolution of a Non-Biological
Protein: Importance of Surface Residues in Protein Fold
Optimization
Matthew D. Smith
1,2, Matthew A. Rosenow
1,2, Meitian Wang
2, James P. Allen
2, Jack W. Szostak
3, John C. Chaput
1,2*
1Center for BioOptical Nanotechnology, The Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America, 2Department of
Chemistry and Biochemistry, Arizona State University, Tempe, Arizona, United States of America, 3Howard Hughes Medical Institute, Department of
Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
Phylogenetic profiling of amino acid substitution patterns in proteins has led many to conclude that most structural
information is carried by interior core residues that are solvent inaccessible. This conclusion is based on the observation that
buried residues generally tolerate only conserved sequence changes, while surface residues allow more diverse chemical
substitutions. This notion is now changing as it has become apparent that both core and surface residues play important roles
in protein folding and stability. Unfortunately, the ability to identify specific mutations that will lead to enhanced stability
remains a challenging problem. Here we discuss two mutations that emerged from an in vitro selection experiment designed
to improve the folding stability of a non-biological ATP binding protein. These mutations alter two solvent accessible residues,
and dramatically enhance the expression, solubility, thermal stability, and ligand binding affinity of the protein. The
significance of both mutations was investigated individually and together, and the X-ray crystal structures of the parent
sequence and double mutant protein were solved to a resolution limit of 2.8 and 1.65 A ˚, respectively. Comparative structural
analysis of the evolved protein to proteins found in nature reveals that our non-biological protein evolved certain structural
features shared by many thermophilic proteins. This experimental result suggests that protein fold optimization by in vitro
selection offers a viable approach to generating stable variants of many naturally occurring proteins whose structures and
functions are otherwise difficult to study.
Citation: Smith MD, Rosenow MA, Wang M, Allen JP, Szostak JW, et al (2007) Structural Insights into the Evolution of a Non-Biological Protein:
Importance of Surface Residues in Protein Fold Optimization. PLoS ONE 2(5): e467. doi:10.1371/journal.pone.0000467
INTRODUCTION
We are interested in the extent to which nature samples the total
structural diversity available in protein sequence space [1,2]. In
pursuit of finding novel proteins with properties similar to natural
proteins,we havediscoveredthat functional proteinscanbe selected
from large unconstrained libraries of random amino acid sequences
[1]. The non-biological proteins that emerge from these selections
are discovered in much the same way that aptamers are selected
from largepoolsofDNAand RNA[3].Wecall thisapproachdenovo
protein evolution since the in vitro process of selection and
amplification closely mimics the natural process of Darwinian
evolution. In these experiments we explore how functional proteins
evolve by imposing a selective pressure on a diverse population of
unrelated sequences to enrich for molecules with a desired
functional property. By starting from a random pool of proteins
we attempt to sample broad regions of protein sequence space for
different independent solutions to a given functional problem.
Following several rounds of selection, we then recover the
descendents of rare functional proteins that originated from starting
libraries as large as 10
13 different sequences. It is important to note
that while our starting libraries are large by conventional standards,
the total number of sequences analyzed represents an extremely
sparse sampling of all possible sequence combinations, indicating
that protein sequence space is surprisingly rich in functional
diversity. In contrast to de novo protein design, which often relies on
genetic algorithms to predict sequences consistent with a predeter-
mined secondary or tertiary structure [4,5], the process of de novo
proteinevolutionrequiresnopriorknowledgeof a protein’s structureor
mechanism in order for a selection to be successful. As a result,
larger regions of the protein universe can be explored for protein
structures that are unanticipated and therefore potentially much
more novel than structures predicted by design.
Initial experiments in de novo protein evolution began with an
attempt to ascertain the frequency of ATP binding proteins in
a sampling of all possible sequences in a contiguous library of 80
amino acids [1]. Here functional activity was viewed as the ability
to bind a desired small molecule target with high affinity and
specificity. Given that many protein domains have sequence
lengths between 50 and 100 amino acids and ATP binding
proteins are present in every major enzyme class, we felt that the
random region and target choice were appropriate to identify
small protein domains with simple ligand binding activity [6].
Because the probability of finding functional domains in
a stochastic sampling of protein sequences was anticipated to be
very low, perhaps too low to detect with conventional technolo-
gies, we used a cell-free selection system called messenger RNA
display to construct a starting library of greater than 10
12 non-
redundant random-sequence proteins [7].
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protein sequences were identified that bound ATP. One of these
proteins (Family B) was optimized by directed evolution for
improved binding affinity. DNA sequencing of the output from
this selection revealed a distant clone (clone 18-19) that differed
from the consensus sequence at 15 out of 80 positions and bound
ATP with far greater affinity and specificity than all other clones
from that round of selection [1]. The X-ray crystal structure for
protein 18-19 was originally solved by Lo Surdo et al. and found to
adopt a novel zinc-nucleated a/b-fold not yet observed by nature
[8]. Structural comparison of protein 18-19 with the databank of
biological protein folds revealed that our de novo evolved protein
shared certain structural features with some proteins found in
nature. These include a ligand binding site with stacking and
electrostatic interactions similar to many natural nucleotide
binding proteins and a zinc-binding site that is structurally
analogous to the treble clef zinc binding motif [9,10]. The
discovery of close structural analogs between proteins that clearly
do not share a common evolutionary ancestor suggests that certain
structural motifs may be more common than previously thought,
and may have emerged independently several times. How these
motifs combine in three-dimensional space to form a stably folded
protein might be less conserved.
Unlike many naturally occurring proteins, protein 18-19
requires high concentrations of free ligand in order to remain
stably folded and soluble. In an attempt to overcome this
limitation and to evolve a non-biological protein toward a folded
state that more closely resembles the ligand-independent folded
state of many natural proteins, we designed an in vitro selection
experiment using mRNA display to isolate variants of protein 18-
19 that remained bound to an ATP agarose affinity resin in the
presence of increasing concentrations of chemical denaturant. Our
goal was to examine the extent to which a de novo evolved protein,
originally selected on the basis of ligand binding affinity, could be
evolved to remain stably folded in the absence of exogenous
ligand. We have previously used this strategy to identify variants of
the Family B protein from a pool of sequences present in the
output of the selection for improved binding affinity [2]. Here the
pool was taken forward without mutagenesis to identify stable
variants from within the existing population of molecules. While
others have used phage display and ribosome display to improve
the folding properties of natural proteins [11,12], neither
technique is capable of achieving both high library complexity
and stable genotype-phenotype linkage under highly denaturing
conditions. mRNA display, by contrast, is a cell-free selection
system based on a covalent amide bond linking newly translated
proteins to their encoding RNA message [13]. The absence of an
in vivo transformation step allows mRNA display to avoid many of
the intrinsic biases associated with cellular expression and to
facilitate the construction of unusually large (.10
13) protein
libraries. We therefore reasoned that it might be possible to use
mRNA-display to evolve a population of ATP binding proteins
that remained stably folded in the absence of excess ligand if such
variants existed and if our starting library contained enough
sequence diversity to examine a significant region of sequence
space around the ATP binding domain.
RESULTS
Library Design and Construction
We began by generating a pool of protein 18-19 variants using
error-prone PCR to produce random point mutations that would
lead to single-residue changes in the protein [14]. Serial
amplification was performed on the entire 240-nt gene-encoding
region with a target mutagenesis rate of 3.5% per amino acid
position. The quality of the pool was evaluated by sequencing 20
clones from the mutagenized DNA library. Analysis of the
individual sequences revealed that the observed mutagenesis rate
closely approximated the expected rate (3.7% versus 3.5% per
amino acid position, respectively) with a roughly equal number of
transitions and transversions. Two minor changes were made to
the constant regions of the library relative to the starting library
used to select protein 18-19. Two out-of-frame stop codons and
a psoralen photo-crosslinking site were introduced downstream of
the open reading frame to enhance fusion formation and reduce
the time and cost of fusion construction.
The DNA library was transcribed into RNA (Fig. 1) and photo-
ligated to a DNA-puromycin linker using a psoralen photocros-
slinking reagent to conjugate the synthetic puromycin linker to the
39-end of the RNA. The pool of RNA-tagged DNA-puromycin
templates was translated in vitro with rabbit reticulocyte lysate to
produce a starting library of mRNA-protein fusions. The mRNA-
Figure 1. Evolutionary Optimization of Protein 18-19 by mRNA Display. The DNA library encodes randomly mutated variants of protein 18-19. For
each round of selection the DNA library was transcribed, photoligated to a 39-puromycin DNA linker, translated, and reverse transcribed to produce
a pool of protein 18-19 variants displayed as mRNA-protein fusions. The library was incubated with ATP derivatized agarose in selection buffer
supplemented with 1.5-3 M GuHCl, washed to remove the unbound material, and eluted with selection buffer containing 10 mM ATP. Eluted
fractions were combined, amplified by PCR, and used as input into the next round of selection.
doi:10.1371/journal.pone.0000467.g001
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agarose columns, and the RNA portion was reverse transcribed with
DNA to prevent the unwanted enrichment of ATP binding RNA
aptamers and to facilitate the amplification of selected proteins after
separation on an ATP-agarose affinity column.
Evolutionary Optimization of Protein 18-19 by
mRNA Display
Evolutionary optimization of a protein fold requires developing
a set of selection conditions that enable the structure to be
optimized without compromising the function of the protein.
Many examples of such trade-offs exist, especially among protein
scaffolds designed to function as antibody mimics, where highly
stable folds are reduced to marginally stable structures after
evolving new functions [15]. We therefore chose to optimize
protein 18-19 using a strategy that has both structural and
functional constraints built into the selection step. Our approach
to this problem involved enriching for well-folded variants by
incubating the pool of mRNA-protein fusions with an ATP-
derivatized affinity resin in the presence of guanidine hydrochlo-
ride (GuHCl). For each round of selection, the GuHCl
concentration was gradually increased from 1.5 M to 3 M in an
effort to ensure that less than 10% of the input to each round of
selection was recovered in the elution step. By inactivating the pool
by at least 90% prior to each round of selection and eluting under
equilibrium conditions with 10 mM free ATP, we aimed to enrich
for ATP binding proteins that remained folded and functional.
Special care was taken to remove the guanidine hydrochloride
prior to DNA amplification by PCR. Analysis of each of the
selection steps in the starting denaturant concentration of 1.5 M
GuHCl (Fig. 2) revealed that the fraction of library that bound to
and eluted from the ATP agarose beads increased in each round,
reaching ,40% at round 4, but not increasing further at round 5.
By contrast, protein 18-19 when constructed as an mRNA-fusion
binds very poorly (,1–2%) to ATP derivatized agarose when
1.5 M GuHCl is present in the binding, wash, and elution buffers.
Sequence Analysis of Selected Proteins
We sequenced 53 clones from the output of round 5 to determine
the sequence changes that led to the improved binding in the
presence of GuHCl. Comparison of the selected sequences
(Table 1a) showed that two amino acid substitutions dominated
the selected population (N32D and D65V, present more than 35
times in 53 different sequences), while 11 other mutations had
become selectively enriched (present more than 5 times in 53
different sequences). To examine this non-biological evolutionary
history, we aligned (Table 1b) the primordial sequence from round
8 of the original selection from which all subsequent clones derive
and the consensus sequence and highest affinity clone (protein 18-
19) from round 18 of the binding optimized selection with the
consensus sequence (protein DX) from the folding optimized
selection performed on protein 18-19. These three sets of
consensus sequences represent distinct stages in the evolutionary
history of the Family B protein from its original discovery in a pool
of 4 trillion random sequences to its optimization for improved
binding and subsequent optimization for improved folding.
Protein 18-19 was the highest affinity sequence from the binding
optimized selection and the parent sequence for the current
selection.
Figure 2. ATP Binding Selection Profile. The proportion of mRNA-
protein fusions that bound to immobilized ATP and eluted with free
ATP in selection buffer supplemented with 1.5 M GuHCl. The pool of
protein variants used as the input into round 1 were generated by
amplification of protein 18-19 under mutagenic conditions. The average
mutagenic rate was 3.5% per amino acid position.
doi:10.1371/journal.pone.0000467.g002
Table 1. Sequence Comparison of the In Vitro Selected Proteins.
a
..................................................................................................................................................
a
Clone 18-19 MDYKDDDDKKTNWLKRIYRVRPCVKCKVAPRNWKVKNKHLRIYNMCKTCFNNSIDIGDDTYHGHDDWLMYADSKEISNT
Protein DX -------------------------------D--------------------------------V--------------
Select mutations -----------------F--G-----R----D-R----Y-------RA---YL-------H---V--------M-----
1 1 0 2 03 0 4 05 06 0 7 0 8 0
b
Primordial MDYKDDDDKKTNWQKRIYRVKPCVICKVAPRDWWVENRHLRIYTMCKTCFSNCINYGDDTYYGHDDWLMYTDCKEFSNT
R18 Consensus --------------------R------------R---------N--------S--------------------------
Protein 18-19 -------------L------R---K------N-K-K-K-----N------N-S-DI-----H--------A-S--I---
Protein DX -------------L------R---K--------K-K-K-----N------N-S-DI-----H--V-----A-S--I---
1 1 0 2 03 0 4 05 06 0 7 0 8 0
aSequences of the Family B proteins from different points in the evolution history of this non-biological protein. Primordial and R18 consensus refer to the consensus
sequences from rounds 8 and 18, respectively, in the original ATP-binding selection. Protein 18-19 was the highest affinity clone isolated from round 18. Protein DX is
the double-mutant protein isolated by optimizing protein 18-19 for improved folding stability. The N32D mutation was present in 35 out 53 sequences. The D65V
mutation was present in 45 out of 53 sequences. Other selected mutations were present $ 5 out of 53 sequences.
doi:10.1371/journal.pone.0000467.t001
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PLoS ONE | www.plosone.org 3 May 2007 | Issue 5 | e467Comparison of the different protein sequences revealed that one
of the two mutations observed in the folding optimized protein
(N32D) reverts an asparagine residue in protein 18-19 back to the
aspartic acid residue present in the primordial sequence. The
second mutation, D65V, was previously observed in a separate
selection experiment designed to improve the folding stability of
the Family B protein pool after optimization for improved binding
affinity [2]. The consensus sequence from that selection (termed
FOB, which stands for folding optimized protein from Family B)
differs from protein DX at 17 out of 80 positions. The fact that
protein 18-19 could achieve a similar degree of optimization with
only two mutations seems to indicate that protein 18-19 was much
closer to achieving structural optimization than other proteins
from round 18 of the binding optimized selection. This is
consistent with the previous observation that protein 18-19
exhibited greater ATP binding affinity than all other clones from
that round of selection.
Protein Expression and Purification
In order to investigation the functional significance of the two
mutations observed in the folding optimized selection for protein
18-19, we cloned protein 18-19, protein 18-19 (N32D), protein 18-
19 (D65V), and protein DX into a pMal plasmid and expressed
the proteins in E. coli as N-terminal fusions of the maltose binding
protein (MBP). Proteins were purified away from the crude lysate
using an amylose affinity resin and quantified by UV spectroscopy.
Comparison of the total amount of fusion protein obtained from
a 1 L expression culture (Table 2) indicated that proteins
containing one or both of the mutations expressed at higher levels
than protein 18-19 (,150 versus ,65 mg/L culture, respectively).
ATP binding proteins (ABP) were further purified by incubating
the fusions with ATP agarose beads, proteolyzing the bound
fusions with thrombin, washing away the MBP with buffer, and
eluting the free ABP with phosphate buffer supplemented with
10 mM ATP. ATP binding proteins were then dialyzed with
phosphate buffer to remove the excess ATP ligand. The two-step
purification yielded highly pure ATP binding proteins suitable for
biophysical characterization.
Biophysical Characterization
We were interested in determining the extent to which our
evolutionary optimization strategy led to protein variants with
improved solubility and folding stability. We began by measuring
the binding affinity (Kd) of each protein for ATP by equilibrium
spin-filtration [16]. Since it was difficult to determine how much
ATP remained bound to the free protein after dialysis, Kd values
were generated using MBP protein fusions. We have used this
approach before to evaluate the binding affinity of other de novo
evolved ATP binding proteins [1,2]. Analysis of the results from
this experiment (Table 2) revealed that the N32D mutation caused
the greatest increase in ATP binding affinity, with a Kd of 360 nM,
relative to protein 18-19, which binds ATP with a Kd of 1100 nM.
Protein DX, which contains both the N32D and D65V mutations,
binds ATP with a Kd of 450 nM and protein 18-19 containing the
D65V mutation binds ATP with a Kd of 650 nM. Together, the
selected mutations represent a ,2-fold increase in ATP binding
affinity over the parent sequence.
To determine how selecting for improved folding stability
correlated with improved protein solubility, we monitored the
time-dependent precipitation of each protein in the absence and
presence of ATP. Amylose purified MBP fusion proteins were
separated into their respective proteins by thrombin proteolysis.
After the proteolysis step, phenylmethylsulfonyl fluoride was added
to the reaction mixture to prevent non-specific degradation of the
ATP binding protein by thrombin. The reaction was then
analyzed after 1, 3, 5, and 7 days by centrifuging the mixture to
separate insoluble aggregates from soluble free protein, and
analyzing the supernatant by SDS gel electrophoresis. Compar-
ison of the individual proteins (Figure 3a) in the absence and
presence of ATP indicated that all four proteins remain fully
soluble after 7 days at room temperature when ATP is present in
the reaction mixture. Experiments performed in the absence of
ATP showed that protein 18-19 forms an insoluble precipitate
Table 2. Properties of Artificial Proteins.
......................................................................
Clone M.W.
a (g/mol) Expression (mg/L) Kd (nM) T50 (uC)
18-19 9696.9 88 1100 6 78 57.5
N32D 9687.1 176 360 6 12 77.1
D65 V 9683.6 131 640 6 28 66.9
DX 9679.5 159 450 6 36 79.5
aMolecular mass determined by maldi-tof mass spectrometry.
doi:10.1371/journal.pone.0000467.t002
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Figure 3. Characterization of the Selected Point Mutations. (A) ATP
binding proteins 18-19, 18-19 (N32D), 18-19 (D65V), and DX were
assayed for solubility in the absence and presence of free ATP. SDS-
PAGE analysis shows that protein variants containing one or both of the
selected mutations remain soluble in the absence of exogenous ATP.
(B) Thermal denaturing curves for protein 18-19 and evolutionary
optimized variants. The thermal stability of proteins 18-19, 18-19
(N32D), 18-19 (D65V), and DX were measured by temperature
dependent circular dichroism at a fixed wavelength of 210 nm. Proteins
containing one or both of the selected mutations exhibit higher relative
thermal stability than the parent sequence.
doi:10.1371/journal.pone.0000467.g003
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PLoS ONE | www.plosone.org 4 May 2007 | Issue 5 | e467after 3 days, while proteins containing one or both of the selected
mutations remain soluble after 7 days. Analysis of the reaction
mixture after 14 and 21 days at room temperature (data not
shown) indicated that protein variants containing one or both of
the selected mutations remained in the soluble fraction. The
improved solubility observed for protein DX indicates that
selecting for folding stability is a valid approach to isolating
protein variants with improved solubility.
In order to determine the contribution of each mutation toward
the improved folding stability of protein DX, we examined the
stability of protein 18-19, protein 18-19 (N32D), protein 18-19
(D65V), and protein DX by thermal denaturation. The stability of
the folded state was measured by monitoring changes in circular
dichroism (210 nm) as a function of temperature. Denaturing
profiles(Fig. 3b) for allfourproteins were measuredintheabsenceof
exogenous ATP. All four proteins gave sigmoidal curves consistent
with a single transition between the native and denatured states. We
were able to determine the relative thermal stability of each protein
by comparing the melting transition (T50), the temperature at which
half of the protein is folded and half unfolded, for the parent protein
and the two mutations individually and together. None of the
proteins melted reversibly and as a result these values represent
relative thermal stabilities rather than thermodynamic parameters.
From this comparison, we found that protein DX exhibits
significantly greater thermal stability than protein 18-19 (79.5uC
versus 57.5uC, respectively). Of the two individual mutations, N32D
appears to be responsible for most of the enhanced thermal stability,
with a T50 of 77.1uC, while the D65V mutation is intermediate in
stability and exhibits a T50 of 66.9uC.
Structural Analysis
We determined the X-ray crystal structures of protein 18-19 and
the evolutionarily optimized variant, protein DX, to resolution
limits of 2.8 A ˚ and 1.65 A ˚, respectively (Table 3, Fig. S1). The
structure of protein 18-19 was solved from the anomalous X-ray
scattering of a zinc ion bound to the protein using multiwavelength
anomalous dispersion (MAD) methods [17]. The structure for
protein DX was initially solved by molecular replacement using
the coordinates from protein 18-19, and later solved independently
using single anomalous dispersion techniques. The Ca backbone
trace of proteins 18-19 and DX can be superimposed (Fig. 4b) with
a root mean square deviation (r.m.s.d.) of 0.51 A ˚ from residues 7
to 71. Both structures closely approximate a previously determined
X-ray crystal structure [8]. As illustrated in Figure 4a, the fold is
characterized by an a-helix (residues 6–20), followed by an
extended loop, then two short b-strands (residues 33–36 and 39–
43), followed by a second a-helix (residues 46–56) that leads to
another extended loop which terminates in a third b-strand
(residues 64–68). The three b-strands form an antiparallel b-sheet
that separates the two a-helices.
The overall fold of the protein is stabilized by the presence of
two cofactors. A zinc metal ion is bound by tetrahedral
Figure 4. The X-ray Crystal Structure of Protein DX. (A) Schematic representation of the Family B scaffold. Mutations N32D and D65V transformed
protein 8-19 into a stably folded water-soluble protein with significantly less ligand dependence than the parent sequence. (B) The three-dimensional
structure (ribbon diagram) of protein DX (gray) superimposed with the parent sequence, protein 18-19 (gold). The zinc metal ion is shown in orange
and the ATP ligand is colored by atom type.
doi:10.1371/journal.pone.0000467.g004
Non-Biological Protein
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46, and 49. The identification of the metal ion as a divalent zinc
atom was unambiguous based on the electron density maps
generated from the multiple anomalous data. The presence of
a zinc metal ion was not unexpected, and we have previously
shown that protein 18-19 was a zinc-binding protein with the zinc
metal required for folding [1]. In addition to the zinc ion, both
structures also contain one ATP molecule bound to the protein in
a well-defined nucleotide binding site. The adenine nucleobase is
buried in a hydrophobic pocket (Fig. 5a) that is stabilized by
stacking interactions involving the aromatic residues Tyr43 and
Phe50 and hydrogen bonding interactions to mainchain carbonyl
oxygens at residue positions Met45 and Gly63. The sugar moiety
adopts a 29-endo conformation with His64 hydrogen bonding with
the 29-hydroxyl group. The presence of several basic amino acid
residues along the b-sheet, including Lys34, Lys36, and Arg41
provide a favorable electrostatic environment for the a-and b-
phosphates, with the orientation of Arg41 controlled by a second
shell of hydrogen bonding to Asp66. The ATP ligand is further
stabilized by coordination to several additional bound water
molecules. The c-phosphate of ATP was less resolved (Fig. 6) in the
electron density map. The large distance of 11 A ˚ between the zinc
atom and the center of the adenine nucleobase indicates that the
zinc metal ion serves a structural role rather than functional role in
ligand binding.
The Asp32 and Val65 amino acid mutations identified during
the evolutionary optimization of protein 18-19 are located on
Table 3. Summary of Crystallographic Data.
......................................................................
18-19 DX
Space group P3221 P3221
a (A ˚) 71.46 72.79
b (A ˚) 71.46 72.79
c (A ˚) 55.26 54.75
Data collection
Detector ADSC Q315 RAXIS IV
Wavelength (A ˚) 1.2830 1.2834 1.2398 1.541
peak inflection remote
Resolution range (A ˚) 30-2.8 30-2.8 30-2.8 50-1.65
Total observations 19,167 16,744 17,881 102,431
Unique reflections 4,235 4,259 4,184 20,360
Redundancy
a 4.3 (4.7) 3.9 (4.0) 4.4 (4.3) 5.0 (4.7)
Completeness (%) 100 (100) 99.9 (100) 99.9 (100) 99.1 (96.9)
,I./,s.
a 6.6 (1.6) 4.4 (1.4) 4.2 (1.8) 17.4 (3.6)
Rsym
a,b 0.099
(0.442)
0.139
(0.497)
0.137
(0.404)
0.056
(0.586)
Model
Rwork 0.238 0.177
Rfree 0.296 0.195
Residues modeled 9-71 5-73
r.m.s.d. bond length (A ˚) 0.020 0.020
r.m.s.d. bond angle (u) 2.139 1.974
Average B factors (A ˚2) 35.1 24.6
all atoms
aValues within parentheses refer to the highest resolution shell.
bRsym=Sh Si (|Ii(h)-,I(h).|)/Sh Si Ii(h), where Ii(h)i st h ei
th intensity
measurement and ,I(h). is the weighted mean of all measurements of I(h).
doi:10.1371/journal.pone.0000467.t003
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Figure 5. Structural Comparison of the Selected Mutations. (A)T h e
region of the ATP binding site contains a network of pi-stacking (Y43 and
F50) and electrostatic interactions (K34, K36, R41, and D66) that mediate
ligand binding. (B) The D65V mutation removes a salt bridge on the
hydrophobic side of the b-sheet and repositions several nearby loops and
side-chains. (C) The N32D mutation caused a change in the electrostatic
environment of the ligand binding site by forming an ion pair with K47.
doi:10.1371/journal.pone.0000467.g005
Non-Biological Protein
PLoS ONE | www.plosone.org 6 May 2007 | Issue 5 | e467opposite sides and faces of the b-sheet. The effects of the two
mutations appear to be independent due to the long distance of
11.2 A ˚ separates the alpha carbons of both residues. In protein 18-
19, Asp65 is located on the hydrophobic face of the third strand
and forms a salt bridge with Arg21, while Asn32 is located on the
polar face of the first strand and contacts the purine base of ATP
through a bridging water interaction. Although the overall fold of
the protein does not change due to the mutations, several
displacements of amino acid side chains and the loops are evident.
The largest structural change occurs as a result of the D65V
mutation (Fig. 5b), which eliminates the R21-D65 salt bridge,
causing a significant repositioning of the Arg21 side chain. The
change in the electrostatic interactions involving Arg21, Arg31,
and Asp65 sidechains leads to a modest shift in the neighboring
loops, with slight repositioning of the Arg31 sidechain. By
comparison, the AsnRAsp mutation at position 32 (Figure 5c)
does not alter the protein backbone, but instead results in an ion
pair between Asp32 and adjacent Lys47, that is critical to
balancing the dense positive charge present in the ATP ligand
binding site. This change is evident when comparing the surface
view of the electrostatic potential for both proteins (Fig. S2).
Indeed a slight repositioning of the Lys47 sidechain toward the
purine nucleobase can be seen in the crystal structure of protein
DX. Small differences in the relative positioning of the ATP
molecules in the two protein structures cannot be resolved due to
the limiting resolution of the 18-19 structure.
DISCUSSION
Proteins are composed of amino acids whose sequence and
identity determine the shape and function of the molecule.
Unfortunately, very little is known about how such complex three-
dimensional information is encoded in a one-dimensional amino
acid sequence. Methods designed to reduce the complexity of this
problem have relied heavily on substitution patterning to
determine the relative tolerance of a particular amino acid
position to change [18–20]. Two dominant approaches have been
used to profile the substitution tolerance of proteins. The first
involves a phylogenetic comparison of the sequences of evolution-
ary related proteins from different organisms [21]. Early work in
this area showed that natural haemoglobin variants tolerated
substitutions at exterior positions much more readily than interior
positions [22,23]. More recent comparisons made with larger data
sets further support the initial finding that interior sites are more
restrictive than exterior sites [24]. Given the large amount of
sequence information currently available in databases of biological
proteins, this method can be extremely effective at profiling amino
acid positions determined by natural selection. The second
approach relies on combinatorial methods, such as cassette
mutagenesis, to identify the constraints on individual positions in
a protein sequence [25]. The technique consists of a stepwise
selection process whereby small sets of neighboring residues are
randomized using degenerate DNA cassettes that encode all 20
naturally occurring amino acids, selected for function, and
sequenced to identify acceptable substitutions. Repeating the
process several times allows for complete coverage of specific
regions of a protein domain or binding interface. Combinatorial
approaches have been used many times to identify the structural
determinants of proteins of both known and unknown structures
[19–25]. Results from initial experiments on the DNA binding
domain of l repressor showed that core residues tend to have
invariant or highly conserved side chains due to the precise nature
of each residue within the jigsaw framework of the hydrophobic
core, while surface residues tend to accept a wider-range of amino
acid substitutions [25]. These and other studies have led to the
general conclusion that amino acid residues that occupy solvent
inaccessible positions in the hydrophobic core carry most of the
information that defines the three-dimensional shape of the
protein, while surface residues help maintain the stability of the
fold [26–30].
In the present study, we used directed evolution to identify
specific amino acid mutations from a pool of randomly mutated
variants that enhance the stability of the protein fold. We then
evaluated the mutations using biophysical methods to determine
the effects of the mutations on the protein. The results from these
experiments revealed that mutations N32D and D65V, located at
solvent exposed positions, significantly enhance protein expression,
solubility, thermal stability, and ligand binding affinity. This
observation supports the notion that surface exposed residues
carry more information that previously thought and make
a significant contribution to protein folding and stability [27–
30]. In evaluating the selected mutations, we wondered whether
the stringent selection conditions used to evolve our non-biological
protein led to the discovery of stabilization factors similar to those
commonly attributed to thermophilic proteins [31]. Although the
structural basis for how thermophilic and hyperthermophilic
proteins achieve enhanced thermostability over their mesophilic
homologues remains unclear, most studies suggest that extreme
thermostability arises from a combination of factors that include
increasing the content of polar charged residues at the expense of
nonpolar sidechains, optimizing the number of electrostatic
interactions, improving core packing, and reducing conformation-
al entropy by minimizing large flexible loops [31,32].
Structural comparison of our evolutionarily optimized protein
to the parent structure (Fig. 5a–c) indicates that protein DX shares
some of the same stabilizing factors as thermophilic proteins. The
N32D mutation changes a polar uncharged residue to a polar
charged residue, which improves the electrostatic environment of
the protein by adding a negatively charged residue to a highly
positively charged region of the protein. Balancing the charge
density at this location was likely critical to stabilizing the protein
in the absence of the ATP ligand. By comparison, the D65V
mutation substitutes a polar charged residue with a non-polar
residue on the hydrophobic side of the b-sheet. This mutation
gives rise to a number of small structural changes, each of which
appears to enhance the stability of the fold, as evident from the
Figure 6. The crystal structure of the ATP ligand bound to the DX
protein with a 2FoFc map contoured at a 1.5 sigma level. The electron
density is much weaker at the gamma phosphate position indicating
that this portion of the molecule is either disordered or has multiple
conformations. The molecule is colored according to atom type.
doi:10.1371/journal.pone.0000467.g006
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mutations. The principle structural change involves the loss of the
R21-D65 salt bridge (Fig. 5b), which leads to a change in the local
electrostatic environment, causing the Arg21 to rotate away from
the hydrophobic face of the b-sheet and reposition in the exposed
solvent. The D65V substitution also causes a modest shift in
nearby loops, which results in the optimization of electrostatic
contacts at nearby residues. Together these smaller structural
changes could reduce the conformational entropy of the protein by
improving local packing and electrostatic interactions previously
constrained by the R21-D65 salt bridge. Calculation of the solvent
exposed surface area for each residue in the protein sequence
indicated that positions 32 and 65 remained unaffected by the
substitutions, reflecting the lack of any significant backbone
changes. While further experiments are needed to define the
precise nature of the N32D and D65V mutations, it is also possible
that these residues may be involved in a complex network of long-
range interactions that help modulate protein folding and ATP
binding activity.
Although many unanswered questions remain about the
amount of information that is necessary to encode a functional
protein, other questions such as why these surface interactions
were not identified in previous substitution experiments are easier
to explain. The most likely reason why surface residues were
initially dismissed in terms of information content resides in the
fact that these interactions are often subtle and difficult to identify,
and that the experimental procedures previously used to identify
amino acid tolerance are often constrained by nature or
experimental design. Both phylogenetic and combinatorial
approaches are limited to the types and number of mutations
found in the final sequence alignment. Here it is often difficult,
without examining each substitution individually, to distinguish
which mutations result from selection and which are caused by
random drift, and the relative importance of each mutation with
respect to fold and function [33]. Combinatorial approaches are
further constrained by the selection conditions used to distinguish
functionally active variants, and the window of residues assayed by
each cassette [34]. In the original cassette mutagenesis studies, for
example, an in vivo assay was used to identify functional variants of
the l repressor. While this assay was able to efficiently distinguish
functional variants from nonfunctional variants, it was less effective
at identifying variants that are both highly active and stably folded.
By contrast, the in vitro selection strategy used to evolve protein 18-
19 for improved folding stability required surviving members from
each round of selection to be well folded and functional. A second
difference between the in vivo approach used for cassette mutagenesis
and the in vitro strategy taken here is that the in vivo assay focuses on
only two or three residues at a time, making it difficult to identify the
cumulative effect of multiple beneficial mutations. This is not to say
that the individual mutations themselves could not be identified
separately by colony screening methods, but rather that the iterative
process of selection and amplification allowed us to converge on
these mutations more rapidly. Overall, the high level of stringency
and the potential to search a large library of broadly dispersed
randompointmutationsarethetwomostlikelyreasonswhywe were
able to identify subtle surface residues with important structural and
functional properties.
The observation that solvent accessible positions carry signifi-
cant amounts of structural and functional information suggests
that it may be possible to optimize many naturally occurring
proteins for improved solubility, folding stability, and functional
activity. Here, we demonstrate that selecting for improved folding
stability is a valid approach to improving the solubility and folding
stability of a non-biological protein from random sequence origin.
We suggest that this approach could be used to obtain well-folded
soluble variants of many biologically relevant proteins whose
structures and functions are otherwise difficult to study. The
heterologous expression of many proteins in E. coli or yeast
remains limited by the stability and solubility of the protein in the
host system. In a particularly striking example, it has been noted
that more than half of the genes in different bacterial species will
require some form of optimization before soluble proteins can be
obtained for crystallization [15]. Evolutionary optimization
strategies that improve the stability of the protein without altering
its backbone have significant value in many ongoing structure-
function studies. Investigating how such changes enhance the
stability of the fold will ultimately lead to a better understanding of
how three-dimensional information is deposited in a one-di-
mensional amino acid sequence.
METHODS
Construction of mRNA-Protein Fusion Library
Mutagenic PCR was used to generate the starting library with an
average mutagenic rate of 3.5% per amino acid position based on
DNA sequencing. The DNA library was amplified by PCR using
the forward primer (59-d-TTC TAA TAC GAC TCA CTA TAG
GGT TTT TAT TTT TAA TTT TCT TTC AAA TAC TTC
CAC CAT GGA CTA CAA AGA CGA CGA CGA T-39) which
contains the sequence information necessary for in vitro transcrip-
tion and translation and the reverse primer (59-d-ATA GCC GGT
GCT ACC GCT CAG ACC CTT CGC AGA TCC AGA CAT
TCC CAT ATG ATG-39) that contains the information necessary
to incorporate a unique three amino acid signature (AKG), two
out-of-frame stop codons, and a psoralen photo-crosslinking site
for ligation to the psoralen-DNA-puromycin oligonucleotide. The
PCR product was phenol/chloroform extracted, ethanol pre-
cipitated, and transcribed with T7 RNA polymerase. The mRNA
library was purified by denaturing PAGE, treated with RQ1
DNase (Promega), phenol/chloroform extracted, and concentrat-
ed by LiCl precipitation. Purified RNA was photochemically
ligated to a psoralen-DNA-puromycin linker (59-psoralen-
TAGCCGGTG-(PEG9)2-dA15CC-puromycin; Glen Research,
underlined positions denote 29-methoxy nucleosides), by irradiat-
ing for 15 min at 366 nm in 96-well microtitler plate (50 ul per
well). The crosslinked material was purified by denaturing PAGE
and translated in vitro by incubating for 1 h at 30uC in 1 ml rabbit
reticulocyte lysate (Nova Red, Novagen) and [
35S]-methionine
(Amersham Biosciences). In situ fusion formation was promoted by
the addition of KCl and MgCl2 to final concentrations of 400 mM
and 50 mM respectively, followed by a second incubation for
15 min at 25uC. mRNA-protein fusions were purified from the
crude lysate by oligo (dT) and Ni-NTA chromatography (Qiagen).
mRNA-protein fusions (100 pmol) were reverse transcribed with
Superscript II RT (Gibco) using the RT-primer (59-d-T15AA CCG
CTC AGC TTG GCC TG-39) to prevent RNA structure
formation during the selection. Approximately 25 pmol of the
starting library was used in the first round of selection.
Selection of ATP-Binding Proteins
Displayed proteins (100 pmol) were incubated with C-8 linked
ATP agarose beads (Sigma) in selection buffer [200 mM Hepes
(pH 7.5), 4 mM MgCl2, 400 mM KCl, 1 mM Na2HPO4, 0.1%
trition X-100, and 10 mM BME] supplemented with 1.5-3 M
GuHCl for 2 h at 25uC in a 5 mL disposable column (Biorad).
The column was drained, washed with 25 column volumes of
selection buffer, and eluted stepwise over 10 min intervals with
0.25 ml aliquots of selection buffer supplemented with 10 mM
Non-Biological Protein
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exchanged into H2O, and PCR amplified. Following five rounds
of selection, the amplified DNA was cloned into a TOPO vector
(Invitrogen) and sequenced (MGH Core Facility).
Protein Expression and Purification
Individual ATP binding proteins (ABP) were inserted into the
pMal expression vector (pIADL14) using Bam HI and Hind III
restriction sites. Plasmid DNA was transformed into one-shot
chemically competent E. coli TOP10 cells (Invitrogen), cloned and
sequenced (ASU Core Facility). Plasmid DNA was subcloned into
E. coli BL21(DE3) strain (Invitrogen) for protein expression.
Bacteria were grown in LB medium supplemented with 0.1 mM
ZnSO4 at 37uCt oa nA 600 of 0.8 and induced with 1 mM IPTG.
Following an additional 4 h of growth, bacteria cells were
harvested by centrifugation and re-suspended in 10 mL of
phosphate buffer (25 mM NaH2PO4 (pH 8.0) and 250 mM
NaCl). Cells were lysed by sonication in the presence of 1 mg/
ml lysozyme. The crude lysate was clarified by filtration through
a 0.45 mm PES filter (Millipore). MBP-fusion proteins were bound
to an amylose column (New England Biolabs), washed with
phosphate buffer and eluted with phosphate buffer supplemented
with 10 mM maltose. MBP-fusion proteins were concentrated
using an Amicon ultrafiltration device (Millipore). Protein
concentration was determined by UV-spectroscopy at 280 nm
using molar extinction coefficients calculated for each sequence.
The yield of pure MBP-ABP fusion protein obtained from a 1 L
culture of induced E. coli was ,65–160 mg. Free ABP protein was
obtained by thrombin proteolysis of the MBP-ABP fusion protein.
MBP-ABP fusion proteins were bound to an ATP agarose column
(Sigma) and cleaved with thrombin (Novagen). Free MBP was
removed by washing with phosphate buffer and free ABP was
eluted with phosphate buffer supplemented with 10 mM ATP.
The eluted ABP was concentrated using a centricon filter
(Millipore) and dialyzed against phosphate buffer. The yield of
pure ABP obtained from a 1 L culture of induced E. coli was ,15–
30 mg.
Thrombin Cleavage Assay for Protein Solubility
MBP-ABP fusion proteins (2 mg/mL) were incubated overnight at
room temperature with thrombin (1 mg/mL, Sigma) to separate
the MBP-ABP fusion into individual proteins. The relative amount
of free ABP that remained in solution was monitored over time (1,
3, 5, and 7 days) by centrifuging the reaction mixture and
analyzing a small aliquot (5 mL) of the supernatant on a 10–20%
gradient SDS-PAGE (Tris-Glycine buffer system, BioRad).
Comparing the band intensity of each mutant protein to the
folding optimized protein provided a direct assessment of relative
solubility.
Determination of Equilibrium Dissociation
Constants
Equilibrium dissociation constants (Kd) for purified MBP-ABP
fusion proteins were measured by equilibrium ultrafiltration.
Apparent Kds were measured using trace c-[
32P]-ATP (Amersham
Biosciences) and a series of concentrations of MBP-ABP fusion
protein spanning the Kd app. The data was iteratively fit (through
nonlinear regression) using the computer program Deltagraph 4.0
(Red Rock Software) to the equation y=b+c((x/(x+Kd app)), where
y is the experimentally measured value (top counts-bottom counts/
top counts), x is the protein concentration, b represents nonspecific
binding to the protein and/or filter, and c is the maximum fraction
of counts that can be bound.
Circular Dichroism
Circular dichroism (CD) spectra were acquired using an Aviv CD
Spectrometer Model 202. Spectra were recorded in phosphate
buffer by monitoring the wavelength dependence of [h]i n1n m
increments with a sampling time of 10 s. Melting curves were
generated by monitoring the change in wavelength dependence of
[h] at 210 nm over a temperature gradient of 24–90uC. T50 values
were determined by curve fitting using the program Deltagraph
4.0 (Red Rock Software).
Protein Crystallization and X-ray diffraction
measurements
The proteins were crystallized using the vapor diffusion technique.
The initial conditions were based upon those described by Lo
Surdo and coworkers with a large number of modifications [8].
The protein solution was prepared in 100 mM sodium phosphate
pH 8.5 and 300 mM sodium chloride rather than 40 mM Tris
HCl pH 7.5, 200 mM sodium chloride. In our protein solution,
the 2 mM DTT reported by LoSurdo was not included but
10 mm ATP was present. The initial conditions yielded small
crystals and after varying the conditions significantly larger crystals
were produced. The optimal conditions for the 1–2 microliter
protein drop are 20 mg/ml protein, 250 mM sodium citrate,
100 mM sodium phosphate pH 8.5, 10 mM ATP, 300 mM
sodium chloride, and 0.4–0.8% x/v polyethylene glycol 400.
The 1 ml reservoir contained 250 mM trisodium citrate and 22–
25% w/v polyethylene glycol 400.
The crystals were frozen to 90 K and found to diffract to
a resolution limit of 2.8 A ˚ belonging to the space group P3221. The
structure of 18-19 was determined by use of multiple anomalous
dispersion (MAD) phasing with diffraction data collected at the
Advanced Light Source, Berkeley CA. A total of three data sets
extending to a resolution limit of 2.8 A ˚ were collected at the peak,
edge, and remote wavelengths for Zn, 1.2830 A ˚,1 . 2 8 3 4A ˚,a n d
1.2398 A ˚, respectively. The diffraction images were processed with
MOSFLM [35] and SCALA [36]. The data are essentially fully
complete to 2.8 A ˚ and yielded excellent phases using SOLVE (figure
of merit 0.40) and an initial model was automatically built using
RESOLVE [37]. After iterations of model rebuilding using COOT
[38] and refinement using REFMAC [39] the final structure has
been refined with peak wavelength data to a Rwork and Rfree of 0.238
and 0.296, respectively (Table 3). The refined model of 18-19 agrees
within experimental error to the previously published structure by
Lo Surdo and coworkers [8]. The protein structure is completely
traced with the exception of the first eight residues forming the
amino terminus and the last seven residues forming the carboxyl
terminus region.
The DX protein structure was subsequently crystallized using
the similar conditions. The crystals were frozen to 110 K and
diffraction data was measured using a Rigaku R-AXIS IV
++
image-plate area detector using Cu Ka radiation from a Rigaku
RU-200HB rotating-anode X-ray generator (50 kV, 100 mA).
The X-ray source was equipped with an Osmic confocal mirror
assembly. The crystals belonged to the same space group as for the
18-19 protein with very similar cell constants but showed
a significantly improved diffraction quality as they diffracted to
a resolution limit of 1.65 A ˚. The diffraction data were integrated
and scaled with HKL2000 [40]. The DX structure was solved by
use of the 18-19 as the search model using the molecular
replacement program MOLREP [41]. The results showed a single
clear peak and the resulting model could be easily refined after
substitution of the altered amino acid residues. The model
rebuilding and refinement were carried out with COOT [38]
Non-Biological Protein
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with the electron density map as shown by the Rwork and Rfree of
0.177 and 0.195, respectively. An additional four residues (5 to 8)
of the amino terminus region and two residues (72 to 73) of the
carboxyl terminus region, which were not resolved in the 18-19
structure are now evident in the electron density maps and have
been included in the DX model. The models were checked with
PROCHECK and MolProbity [42,43]. In addition, the DX1819
data contains weak but significant anomalous signals from one zinc
ion, six sulfurs from cysteine and methionine residues, and one
chloride anion which is located in the 2-fold axis at crystallo-
graphic dimmer interface. In fact, with known positions of these
anomalous scatters, the DX1819 structure could be successfully
phased with SAD phasing method [44] using SHARP [45] and
SOLOMON [46]. This experimental map has an exceptional high
quality, and is completely unbiased (some portions of the map are
shown in (Figure S1). Therefore, this map was also used to validate
the final model upon the completion of the refinement. All figures
were prepared with Pym [47].
SUPPORTING INFORMATION
Figure S1 The three-dimensional structure of protein DX
showing electron density at the zinc and ATP binding sites, and
at residue positions D32 and V65. The electron density map at a 1
sigma level calculated using phases determined using SAD
followed by SHARP analysis.
Found at: doi:10.1371/journal.pone.0000467.s001 (9.77 MB TIF)
Figure S2 Surface view of proteins 18-19 and DX. A positive
electrostatic patch evolved during the course of the ATP binding
selection that led to improved ligand binding affinity for 18-19
(left). The large portion of positive electrostatic charge was later
balanced with increased negative charge during the folding
optimization selection that led to the evolution of protein DX
(right). Positive, negative, and neutral regions are shown in blue,
red, and white, respectively.
Found at: doi:10.1371/journal.pone.0000467.s002 (7.42 MB TIF)
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